Research Publications

Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.

Management of patients who are not candidates for protease inhibitor therapy.

Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients.

Drugs in development for chronic hepatitis C: a promising future.

Response-guided telaprevir combination treatment for hepatitis C virus infection.

A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels.

Telaprevir for retreatment of HCV infection.

Telaprevir for previously untreated chronic hepatitis C virus infection.

Drugs in development for viral hepatitis: care and caution.

Hematologic and oncologic diseases and the liver.